RedHill Biopharma (RDHL) Gross Margin (2014 - 2023)
RedHill Biopharma (RDHL) recorded Gross Margin of 1927.62% in the year ended Dec 31, 2025, up 1867.32 percentage points from 60.30% a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Gross Margin (2014 - 2023) Analysis & Trends
Starting with the year ended Dec 31, 2013, RedHill Biopharma's Gross Margin history includes 13 years.
- Annual Gross Margin has increased for four straight years, with a five-year change of +1884.94 percentage points (years ended Dec 2020 to Dec 2025).
- The figure for the year ended Dec 31, 2025 is the highest annual Gross Margin in data going back to the year ended Dec 31, 2013.
- Per Business Quant data, RDHL's Gross Margin was 60.30% in the year ended Dec 31, 2024 (+13.27 pp), 47.03% in the year ended Dec 31, 2023 (+0.97 pp), 46.06% in the year ended Dec 31, 2022 (+3.67 pp) and 42.39% in the year ended Dec 31, 2021 (-0.29 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | RedHill Biopharma | 7.53 Mn | 7.53 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 55.12% |
| Mar 31, 2023 | 55.21% |
| Dec 31, 2022 | 32.82% |
| Sep 30, 2022 | 46.15% |
| Jun 30, 2022 | 50.97% |
| Mar 31, 2022 | 51.98% |
| Dec 31, 2021 | 12.40% |
| Sep 30, 2021 | 57.29% |
| Jun 30, 2021 | 50.75% |
| Mar 31, 2021 | 50.17% |
| Dec 31, 2020 | 50.37% |
| Sep 30, 2020 | 50.64% |
| Jun 30, 2020 | 32.11% |
| Mar 31, 2020 | -62.41% |
| Dec 31, 2019 | 50.44% |
| Sep 30, 2019 | 55.10% |
| Jun 30, 2019 | 72.81% |
| Mar 31, 2019 | 75.99% |
| Dec 31, 2018 | 57.03% |
| Sep 30, 2018 | 72.89% |
API Access
RedHill Biopharma Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();